Xu H, Ajayan A, Langen R, Chen J
Neurobiol Dis. 2024; 205:106780.
PMID: 39736404
PMC: 11837809.
DOI: 10.1016/j.nbd.2024.106780.
Chang Y, Chen C, Chen Y, Wu M, Lin T, Hua K
J Neuroimmune Pharmacol. 2024; 20(1):1.
PMID: 39621196
DOI: 10.1007/s11481-024-10161-7.
Feleus S, Skotnicki L, Roos R, de Bot S
Mov Disord Clin Pract. 2024; 11(12):1530-1541.
PMID: 39431460
PMC: 11647978.
DOI: 10.1002/mdc3.14230.
Yang K, Quiroz V, Tam A, Srouji R, Villanueva X, Amarales C
Ann Clin Transl Neurol. 2024; 11(10):2805-2810.
PMID: 39239850
PMC: 11514935.
DOI: 10.1002/acn3.52193.
Witmer A, Bhanu B
Sci Rep. 2024; 14(1):4489.
PMID: 38396157
PMC: 10891062.
DOI: 10.1038/s41598-024-54993-y.
Comparison of Huntington's disease phenotype progression in male and female heterozygous FDNQ175 mice.
Li S, Colson T, Chen J, Abd-Elrahman K, Ferguson S
Mol Brain. 2023; 16(1):67.
PMID: 37726802
PMC: 10508000.
DOI: 10.1186/s13041-023-01054-6.
Rat cortico-striatal sagittal organotypic slice cultures as excitotoxic striatal lesion models.
McCaughey-Chapman A, Connor B
Heliyon. 2022; 8(9):e10819.
PMID: 36193519
PMC: 9525915.
DOI: 10.1016/j.heliyon.2022.e10819.
CAG Repeat Instability in the Peripheral and Central Nervous System of Transgenic Huntington's Disease Monkeys.
Cho I, Clever F, Hong G, Chan A
Biomedicines. 2022; 10(8).
PMID: 36009409
PMC: 9405741.
DOI: 10.3390/biomedicines10081863.
Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington's disease.
Di Tella S, Lo Monaco M, Petracca M, Zinzi P, Solito M, Piano C
J Neurol. 2022; 269(12):6634-6640.
PMID: 35915275
DOI: 10.1007/s00415-022-11297-3.
Ginsenoside compound K reduces the progression of Huntington's disease via the inhibition of oxidative stress and overactivation of the ATM/AMPK pathway.
Hua K, Chao A, Lin T, Chen W, Lee Y, Hsu W
J Ginseng Res. 2022; 46(4):572-584.
PMID: 35818427
PMC: 9270658.
DOI: 10.1016/j.jgr.2021.11.003.
A selective inhibitor of the NLRP3 inflammasome as a potential therapeutic approach for neuroprotection in a transgenic mouse model of Huntington's disease.
Chen K, Hua K, Tsai F, Lin T, Cheng C, Yang D
J Neuroinflammation. 2022; 19(1):56.
PMID: 35219323
PMC: 8882273.
DOI: 10.1186/s12974-022-02419-9.
Metabotropic Glutamate Receptor 5 Antagonism Reduces Pathology and Differentially Improves Symptoms in Male and Female Heterozygous zQ175 Huntington's Mice.
Li S, Colson T, Abd-Elrahman K, Ferguson S
Front Mol Neurosci. 2022; 15:801757.
PMID: 35185467
PMC: 8847794.
DOI: 10.3389/fnmol.2022.801757.
Moderate Intensity Exercise in Pre-manifest Huntington's Disease: Results of a 6 months Trial.
Aldine A, Ogilvie A, Wemmie J, Kent J, Schultz J, Long J
SVOA Neurol. 2022; 2(1):6-36.
PMID: 35128541
PMC: 8815110.
Generative Adversarial Networks for Morphological-Temporal Classification of Stem Cell Images.
Witmer A, Bhanu B
Sensors (Basel). 2022; 22(1).
PMID: 35009749
PMC: 8749838.
DOI: 10.3390/s22010206.
Gauging the role and impact of drug interactions and repurposing in neurodegenerative disorders.
Khatri D, Kadbhane A, Patel M, Nene S, Atmakuri S, Srivastava S
Curr Res Pharmacol Drug Discov. 2021; 2:100022.
PMID: 34909657
PMC: 8663985.
DOI: 10.1016/j.crphar.2021.100022.
Hearing Loss in Neurological Disorders.
Li S, Cheng C, Lu L, Ma X, Zhang X, Li A
Front Cell Dev Biol. 2021; 9:716300.
PMID: 34458270
PMC: 8385440.
DOI: 10.3389/fcell.2021.716300.
Juvenile Huntington's Disease and Other PolyQ Diseases, Update on Neurodevelopmental Character and Comparative Bioinformatic Review of Transcriptomic and Proteomic Data.
Switonska-Kurkowska K, Krist B, Delimata J, Figiel M
Front Cell Dev Biol. 2021; 9:642773.
PMID: 34277598
PMC: 8281051.
DOI: 10.3389/fcell.2021.642773.
Exploring the Role of Autophagy Dysfunction in Neurodegenerative Disorders.
Rana T, Behl T, Sehgal A, Mehta V, Singh S, Bhatia S
Mol Neurobiol. 2021; 58(10):4886-4905.
PMID: 34212304
DOI: 10.1007/s12035-021-02472-0.
Neuroprotective Potential of Caffeic Acid Phenethyl Ester (CAPE) in CNS Disorders: Mechanistic and Therapeutic Insights.
Kulkarni N, Vaidya B, Narula A, Sharma S
Curr Neuropharmacol. 2021; 19(9):1401-1415.
PMID: 34102977
PMC: 8762179.
DOI: 10.2174/1570159X19666210608165509.
Advances in Applying Computer-Aided Drug Design for Neurodegenerative Diseases.
Salman M, Al-Obaidi Z, Kitchen P, Loreto A, Bill R, Wade-Martins R
Int J Mol Sci. 2021; 22(9).
PMID: 33925236
PMC: 8124449.
DOI: 10.3390/ijms22094688.
